Nov 19O1,369.38H1,382.00L1,341.46C1,351.32Vol1.714M
Lilly Eli Co stock is traded at $1,350.74, with a volume of 1,979,979. It is down -2.32% in the last 24 hours and up +8.90% over the past month. Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Previous Close:
$1,382.75
Open:
$1,369.38
24h Volume:
1,979,979
Relative Volume:
0.64
Market Cap:
$1.20T
Revenue:
$72.25B
Net Income/Loss:
$25.28B
P/E Ratio:
48.62
EPS:
$27.78
Net Cash Flow:
$10.37B
1W Performance:
-5.36%
1M Performance:
+8.90%
6M Performance:
+32.24%
1Y Performance:
+28.69%
1-Day Range:
$1,341.46$1,382.00
1-Week Range:
$1,341.46$1,475.25
52-Week Range:
$850.51$1,475.25
Lilly Eli Co Stock (LLY) Company Profile
Name
Lilly Eli CoSector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
(317) 276-2000Address
LILLY CORPORATE CTR, INDIANAPOLIS, IN, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS